Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity

Osteosarcoma is the most common primary bone tumor, with a poor prognosis owing to the lack of efficient molecular-based targeted therapies. Previous studies have suggested an association between CD151 and distinct consequences in osteosarcoma tumorigenicity. However, the potential of CD151 as a the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongsheng, Jin, Xinmeng, Zhang, Yangfeng, Wang, Zhuoying, Zhang, Tao, Xu, Jing, Shen, Jiakang, Zan, Pengfei, Sun, Mengxiong, Wang, Chongren, Hua, Yingqi, Ma, Xiaojun, Sun, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548188/
https://www.ncbi.nlm.nih.gov/pubmed/36209197
http://dx.doi.org/10.1186/s13578-022-00900-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548188/
https://www.ncbi.nlm.nih.gov/pubmed/36209197
http://dx.doi.org/10.1186/s13578-022-00900-9

Ejemplares similares